J. Bizjak

Ljubljana University Medical Centre

Papers

1

Total Citations

2

H-Index

1

About

J. Bizjak is a clinical researcher whose work centers on the surgical management of kidney tumors, with a particular focus on robot-assisted partial nephrectomy (RAPN) and its oncologic outcomes. Their most cited study, "Does tumor rupture during robot-assisted partial nephrectomy have an impact on mid-term tumor recurrences?" (2023), addresses a critical gap in urologic oncology: the lack of clear guidelines for managing intraoperative tumor rupture. By investigating whether such ruptures affect mid-term recurrence rates, Bizjak provides essential evidence that informs surgical decision-making and patient counseling. This work has already garnered 2 citations, underscoring its relevance to practicing surgeons and researchers. Bizjak’s contributions are notable for tackling a common yet understudied complication in minimally invasive kidney surgery, helping to refine best practices in RAPN. Their research is particularly valuable for urologists and trainees seeking to understand the real-world implications of surgical events on long-term cancer control, making Bizjak a key voice in the ongoing effort to optimize outcomes for renal cell carcinoma patients.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Does tumor rupture during robot-assisted partial nephrectomy have an impact on mid-term tumor recurrences?
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Ljubljana University Medical Centre

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago